Agenus Inc.
AGEN
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$3.69
FAIR PRICE
$3.55
MARGIN
$0.14
P/E Ratio
N/A
Div. Yield
N/A
ROE
10.8%
Market Cap
$138M
Small-cap
COMING SOON
Get notified when AGEN's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Garo H. Armen
COUNTRY
US
HEADQUARTERS
Lexington
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate AGEN's fair price
Agenus Inc.'s fair price of $3.55 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $3.69, AGEN trades 3.8% above its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting AGEN's risk profile.
RELATIVE · 30%
Comparing AGEN's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for AGEN, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for AGEN.
Explore on BuliosFAQ
What is the fair price of AGEN?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Agenus Inc. is $3.55. At the current market price of $3.69, AGEN trades 3.8% above its calculated fair value.
Is AGEN overvalued or undervalued?+
Agenus Inc. is currently fair based on our valuation model. The stock trades at $3.69, which is 3.8% above the fair price of $3.55.
How often is AGEN's fair price updated?+
We update fair price calculations for AGEN daily after market close. The current fair price of $3.55 incorporates the latest market data and sector multiples.
What factors affect AGEN's fair price calculation?+
AGEN's fair price of $3.55 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of 10.8%.
Is AGEN a good buy right now?+
At $3.69, AGEN trades 3.8% above our fair value estimate of $3.55. The stock is currently fair. ROE stands at 10.8% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does AGEN pay dividends?+
AGEN does not currently pay a dividend.